Recommendations for the Design of Clinical Drug-Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically-Based Pharmacokinetic Model.

MLA

Chen, Yuan, et al. “Recommendations for the Design of Clinical Drug-Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically-Based Pharmacokinetic Model.” CPT: Pharmacometrics & Systems Pharmacology, vol. 8, no. 9, Sept. 2019, pp. 685–95. EBSCOhost, https://doi.org/10.1002/psp4.12449.

APA

Chen, Y., Cabalu, T. D., Callegari, E., Einolf, H., Liu, L., Parrott, N., Peters, S. A., Schuck, E., Sharma, P., Tracey, H., Upreti, V. V., Zheng, M., Zhu, A. Z. X., & Hall, S. D. (2019). Recommendations for the Design of Clinical Drug-Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically-Based Pharmacokinetic Model. CPT: Pharmacometrics & Systems Pharmacology, 8(9), 685–695. https://doi.org/10.1002/psp4.12449

Chicago

Chen, Yuan, Tamara D Cabalu, Ernesto Callegari, Heidi Einolf, Lichuan Liu, Neil Parrott, Sheila Annie Peters, et al. 2019. “Recommendations for the Design of Clinical Drug-Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically-Based Pharmacokinetic Model.” CPT: Pharmacometrics & Systems Pharmacology 8 (9): 685–95. doi:10.1002/psp4.12449.